Wordt geladen...
Total knee replacement with and without emicizumab: a unique comparison of perioperative management
Prophylaxis with emicizumab was used in a patient with severe hemophilia with an inhibitor who underwent knee surgery. Use of emicizumab during surgery led to less recombinant factor VIIa and less bleeding, in addition to cost savings, for this patient.
Bewaard in:
| Gepubliceerd in: | Blood Adv |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7065482/ https://ncbi.nlm.nih.gov/pubmed/32126140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019001060 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|